West Pharmaceutical Services EBIT 2010-2024 | WST

West Pharmaceutical Services EBIT for the quarter ending September 30, 2024 was $0.161B, a 9.02% decline year-over-year.

  • West Pharmaceutical Services 2023 EBIT was 0.676B, a 7.9% decline from 2022.
  • West Pharmaceutical Services 2022 EBIT was 0.734B, a 2.43% decline from 2021.
  • West Pharmaceutical Services 2021 EBIT was 0.752B, a 84.89% increase from 2020.

EBIT can be defined as earnings before interest and taxes.

West Pharmaceutical Services EBIT 2010-2024 | WST

  • West Pharmaceutical Services 2023 EBIT was 0.676B, a 7.9% decline from 2022.
  • West Pharmaceutical Services 2022 EBIT was 0.734B, a 2.43% decline from 2021.
  • West Pharmaceutical Services 2021 EBIT was 0.752B, a 84.89% increase from 2020.

EBIT can be defined as earnings before interest and taxes.
Related Stocks
Company NameMarket
Cap
McKesson (MCK)$79.1B
Becton Dickinson (BDX)$64.7B
Cardinal Health (CAH)$29.5B
Cooper (COO)$20.1B
Labcorp (LH)$20B
Align Technology (ALGN)$16.9B
Henry Schein (HSIC)$9.4B
Merit Medical Systems (MMSI)$6.1B
DENTSPLY SIRONA (XRAY)$3.7B
CONMED (CNMD)$2.3B
Patterson (PDCO)$1.8B
STAAR Surgical (STAA)$1.3B
Lifevantage (LFVN)$178M
Pro-Dex (PDEX)$152M